Synthetic Data

First SYNTHIA policy papers published. SYNTHIA supports policymakers by translating technical advances in synthetic data into policy-relevant guidance and evidence.

At ESMO 2026 in Madrid, SYNTHIA joined the conversation on turning advances in personalised oncology into practical solutions for healthcare, while showcasing new research on the potential of AI to make clinical data more accessible and useful.

On 5 October 2026, the SHAIPED Stakeholder Forum brought together various stakeholders. Among the contributors was SYNTHIA Partner Ahmed Youssef Ali from Johnson & Johnson Innovative Medicine.

On 20–21 October 2026, SYNTHIA was represented at the Innovative Health Initiative (IHI) Forum 2026 in Brussels, Belgium.

Two years into SYNTHIA, the project is entering an important new phase. With methods being developed, data being prepared, use cases progressing and the SYNTHIA Platform taking shape.

On World Cancer Research Day, SYNTHIA joins the global community in highlighting the importance of continued research, collaboration and innovation to advance cancer prevention, diagnosis, treatment and care.

Insight featuring Stella (Styliani-Christina) Fragkouli from CERTH.

On World Alzheimer’s Day, observed during World Alzheimer’s Month, SYNTHIA joins the global community in raising awareness of Alzheimer’s disease.

EU Cancer Mission marks five years. SYNTHIA is contributing by exploring how synthetic data can help overcome some of the data challenges that continue to limit cancer research and innovation.

During Blood Cancer Awareness Month, SYNTHIA joins the global community in raising awareness of blood cancers and highlighting the importance of continued research and innovation.

On World Breast Cancer Research Day, SYNTHIA joins the global community in recognizing the importance of continued research and innovation to improve breast cancer detection, treatment and outcomes.

Health Technology Assessment (HTA) and regulatory engagement are essential.

Insight featuring Gianluca Asti from Humanitas.

On World Lung Cancer Day, SYNTHIA joins the global community in raising awareness and driving progress for people affected by lung cancer — through research, innovation and collaboration.

On World Brain Day, SYNTHIA joins the global community in raising awareness of brain health and the need to advance research into neurological diseases.

Insight featuring Mattia Delleani Founding Engineer at TRAIN.

SYNTHIA is inviting citizens across Europe to take part in an important new survey exploring public perspectives on synthetic data in healthcare.

Insight featuring Bogdan Kulynych and Jean Louis Raisaro from Biomedical Data Science Center of Lausanne University Hospital (CHUV).

Insight featuring Alejandro Almodóvar, Juan Parras, and Santiago Zazo from Universidad Politécnica de Madrid (UPM).

SYNTHIA was represented at the Innovative Health Initiative (IHI) Coordinators Training Day in Brussels.

Interview with Vibeke Binz Vallevik and Serena Elizabeth Marshall from DNV.

SYNTHIA is inviting citizens across Europe to take part in an important new survey exploring public perspectives on synthetic data in healthcare.

On World Health Day, SYNTHIA joins the global community in recognising the importance of improving health outcomes for people worldwide.

Interview with Stella (Styliani-Christina) Fragkouli from CERTH and Nagat Masued from BSC.

Interview with Tim Adams and Yasamin Salimi from Fraunhofer.

Partnership and shared learning are essential to unlocking synthetic data’s potential for safe and meaningful healthcare innovation.

During Brain Awareness Week, SYNTHIA joins the global effort to raise awareness about the importance of brain health and the impact of neurological disorders on millions of people worldwide.

SYNTHIA hosted a high-level panel discussion at the ICT&health World Conference 2026 in Maastricht, The Netherlands.

Highlighting the urgent need for innovation in areas where limited data, small patient populations and complex trial design continue to slow progress.

A year of research, results and scientific contribution.

A year of presence, dialogue and connections at conferences and forums.

Discover how the HealthData4EU Collaborative came together at the European Big Data Value Forum 2025

The SYNTHIA platform will empower the community to ask new questions of data, and uncover the answers that matter for future healthcare.

By addressing synthetic data from multiple angles and use cases, SYNTHIA is positioned to show its real clinical value.

Health Technology Assessment (HTA) and regulatory engagement are essential.

Working together across institutions will be essential as SYNTHIA turns its vision into real, clinically meaningful synthetic data solutions.

Our collective effort will be central to its success in shaping the future of synthetic data for medicine.

SYNTHIA Co-Chair Holger Fröhlich, Fraunhofer discussed the growing role of AI-based synthetic patient data in healthcare

ICT&health spotlights SYNTHIA in article "Synthetic Data: Medical research without GDPR headaches?"

Interview with Jean-Louis Raisaro, Bogdan Kulynych and Bayrem Kaabachi from CHUV.

SYNTHIA participated in the IHI workshop which provided the input for the report.

Health Technology Assessment (HTA) and regulatory engagement are essential components of the SYNTHIA project.

Interview with SYNTHIA partner Saverio D’Amico from TRAIN.

The insights gathered will help define the foundation of SYNTHIA’s framework, ensuring that its solutions are aligned with real-world demands.

In these short video interviews, our partners share their role in SYNTHIA and their visions.

The beginning of our groundbreaking initiative, bringing together leading experts to revolutionize synthetic data generation.